Skip to main content

User account menu

  • Log in
  • Register
  • Contact
BandwidthHigh

Language switcher

  • English
  • Français
  • Español

Main navigation

    • Our work
    • Rationale
    • IDDO Team
    • Contact us
    • Our partners
    • IDDO Board
    • Data Access Committees
    • Contributing data
    • Accessing data
    • IDDO data sharing registrations
    • COVID-19
    • Ebola
    • Malaria
    • Visceral leishmaniasis
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Febrile illness
    • Scrub typhus
    • Other diseases
    • Malaria Tracking Resistance
    • Malaria Clinical Trials Toolkit
    • COVID-19 LSR Tool
    • VL Tool
    • Medicine Quality Monitoring Globe
    • Medicine Quality Scientific Literature Surveyor
    • Febrile Illness Surveyor
    • Publications
    • Tools & resources
  • News

WWARN News

Please visit WWARN's website for regular updates on malaria and sign up for the WWARN newsletter here. 

Credit: Pearl Gan
Cardiovascular Safety is important when treating patients with antimalarials. Photo: Ami Vitale / World Bank Ivory Coast
Tuesday, 4 December 2018

Assessing the effect of antimalarial medicines on the heart’s rhythm

Malaria is the leading cause of parasitic disease, killing nearly half a million people per year, most of whom are African children. Recent figures from the World Health Organization indicate that the decline in the number of infections and deaths annually has stalled. We are once again at a critica...
Over 200 delegates attended MPQH 2018
Wednesday, 14 November 2018

MQPH 2018 conference participants sign Oxford Statement in a pledge to radically improve medicine quality

Over 30 organisations have so far signed the Oxford statement developed by IDDO and the Medicines We Can Trust campaign during the first ever-academic conference on Medicine Quality and Public Health in Oxford, 23-28 September.
web_size_wwarn.jpg
Tuesday, 13 November 2018

MQPH 2018 conference participants sign Oxford Statement in a pledge to radically improve medicine quality

Over 40 organisations have so far signed the Oxford statement developed by IDDO and the Medicines We Can Trust campaign during the first ever-academic conference on Medicine Quality and Public Health in Oxford, 23-28 September.
Original artworks on display at MQPH 2018
Monday, 12 November 2018

PHARMACIDE ARTS - Fake medicine: the disease of greed

If you’re in Oxford, UK between now and January 4th, 2019 visit the Radcliffe Science Library at the University of Oxford to see a new art exhibition of 14 prints illustrating the global health impact of poor quality medicines.
Dr Mahamoud Sama Cherif presenting his poster on creating an equitable governance framework for IDDO’s Ebola research theme, credit: EDCTP forum.
Friday, 9 November 2018

Highlights from the 9th EDCTP Forum in Lisbon

Researchers from IDDO and the WorldWide Antimalarial Resistance Network (WWARN) presented at the 9th European and Developing Countries Clinical Trials Partnership (EDCTP) forum held in Lisbon, Portugal from 17-21 September 2018.
istock-stethoscope-in-doctors-coat-picture-website-page-resize-bought.jpg
Wednesday, 7 November 2018

Reviewing the Cardiovascular Safety Profile of Antimalarial Drugs

Quinoline antimalarial drugs are vital tools in the fight against malaria. However, their possible effect on the heart’s rhythm raises safety concerns which may limit their use.
unamid-flikr-el-sereif-darfur-crisis-may-2013-albert-gonzalez-farran-cropped.jpg
Monday, 5 November 2018

Malaria and malnutrition – assessing the risks for small children

A WWARN Study Group recently published a large systematic literature review to understand whether undernutrition places children at higher, lower, or no differential risk for malaria. The goal was to evaluate evidence to help optimise antimalarial treatment strategies and support global health pract...
Scientist in protective clothing
Thursday, 1 November 2018

Ebola Data Access Committee call for nominations

IDDO’s Ebola Data Platform, a pioneering collaboration in Ebola and emerging infections, has opened nominations for members of its Data Access Committee (DAC). Individuals with skills and expertise in clinical research, data protection and management, ethics in research and emergency public health r...
IDDO stand at ASTMH
Thursday, 25 October 2018

ASTMH 2018 is starting soon – find out more about our activities in New Orleans

If you’re planning to be at this year’s 67th American Society of Tropical Medicine and Health Annual Meeting in New Orleans, then do come and see us. We’ll be sharing our latest results and tools at Booth 416 – so do stop by to meet the IDDO team to exchange ideas on how we might work together.
molecular-surveyor-k13-screenshot_0.jpg
Wednesday, 24 October 2018

We've updated our visualisation tools

The latest results are now live on three WWARN surveyors:
astmh-2017-ccvtm-wwarn-stand.jpg
Wednesday, 24 October 2018

ASTMH 2018 has begun – discover our activities in New Orleans

ASTMH is upon us – we look forward to seeing many of our partners in the USA very soon.
mqph_audi9ence_websize.jpg
Tuesday, 23 October 2018

Sparking new collaboration and multi-stakeholder discussion on substandard and falsified medicines at MQPH 2018

Over 200 delegates traveled from more than 50 countries to attend the first ever conference on Medicine Quality and Public Health (MQPH) in Oxford from 23-28 September 2018.
ninth-edctp-forum_31481078178_o.jpg
Monday, 22 October 2018

Highlights from the 9th EDCTP Forum in Lisbon

Researchers from WWARN and the Infectious Diseases Data Observatory (IDDO) presented at the 9th European and Developing Countries Clinical Trials Partnership (EDCTP) forum held in Lisbon, Portugal from 17-21 September 2018.
mqph-2018-iddo-stand-visitor.jpg
Sunday, 23 September 2018

First ever international conference on Medicine Quality and Public Health this month

The Infectious Diseases Data Observatory (IDDO), together with WWARN and many partners including the United States Pharmacopeia (USP), the Concept Foundation, the Mahidol Oxford Tropical Medicine Research Unit (MORU) and the Wellcome Trust are hosting the first Medicine Quality and Public Health con...
MQPH 2018 conference
Friday, 21 September 2018

First ever international conference on Medicine Quality and Public Health starts soon in Oxford

The Infectious Diseases Data Observatory (IDDO), together with many partners including the United States Pharmacopeia (USP), the Concept Foundation, the Mahidol Oxford Tropical Medicine Research Unit (MORU) and the Wellcome Trust will host the first Medicine Quality and Public Health conference at K...
Sama Cherif presenting at ‘Data-sharing for global research good’ symposium
Tuesday, 18 September 2018

9th EDCTP Forum starts this week

We are delighted to attend the 9th EDCTP Forum in Lisbon, Portugal this week.
img-20180918-wa0003.jpg
Tuesday, 18 September 2018

9th EDCTP Forum starts this week

We are delighted to attend the 9th EDCTP Forum in Lisbon, Portugal this week.
The economic costs of antimicrobial resistance (AMR) are higher than the sales price of most popular antibiotics, according to a recent MORU/IDDO study. Curbing the unnecessary use of antibiotics is key to dealing with the AMR issue head on, particularly in SE Asia, which has the highest rates of AMR and a big, informal medicine dispensing sector that aggravates the AMR problem. ©2018 MORU/Wellcome.
Wednesday, 22 August 2018

Study details high hidden economic costs of antibiotic consumption

Bangkok / Oxford, 22 August 2018 – The economic costs of antimicrobial resistance (AMR) for every course of antibiotics are considerable, and much higher than their purchase cost, say researchers.
Credit: iStock
Friday, 3 August 2018

Applications Open for Global Health Journalism Fellowship

The 2018 Global Health Journalism Fellowship will invite outstanding young journalists to participate in the first ever international conference on Medicine Quality and Public Health at the University of Oxford. Application deadline is 12 August 2018
alex_kumar_resized.png
Monday, 23 July 2018

DFID announces support for triple ACT trials in Asia and Africa

The UK’s Department for International Development (DFID) recently announced that it will commit £9.2 million (USD 13.15 million) of funding to support a new malaria research programme lead by the Mahidol-Oxford Research Unit (MORU). The programme entitled ‘Development of Triple Artemisinin Combinati...

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Current page 8
  • Page 9
  • Page 10
  • Next page ››
  • Last page Last »
Sign up for our newsletter Twitter LinkedinIDDO on YoutubeRSS

Footer menu

  • Cookies
  • Privacy Notice
  • Accessibility
  • Sitemap
  • Terms of use
© 2022 Infectious Diseases Data Observatory